| 000 | 01884 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514155552.0 | ||
| 264 | 0 | _c20031103 | |
| 008 | 200311s 0 0 eng d | ||
| 022 | _a0042-6822 | ||
| 024 | 7 |
_a10.1016/s0042-6822(03)00459-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuthumani, Karuppiah | |
| 245 | 0 | 0 |
_aNovel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo. _h[electronic resource] |
| 260 |
_bVirology _cSep 2003 |
||
| 300 |
_a134-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
| 650 | 0 | 4 |
_aEnhancer Elements, Genetic _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Products, rev _xgenetics |
| 650 | 0 | 4 |
_aHIV Antibodies _xblood |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp160 _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aMason-Pfizer monkey virus _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aT-Lymphocytes, Cytotoxic |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 650 | 0 | 4 | _arev Gene Products, Human Immunodeficiency Virus |
| 700 | 1 | _aZhang, Donghui | |
| 700 | 1 | _aDayes, Nathanael S | |
| 700 | 1 | _aHwang, Daniel S | |
| 700 | 1 | _aCalarota, Sandra A | |
| 700 | 1 | _aChoo, Andrew Y | |
| 700 | 1 | _aBoyer, Jean D | |
| 700 | 1 | _aWeiner, David B | |
| 773 | 0 |
_tVirology _gvol. 314 _gno. 1 _gp. 134-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0042-6822(03)00459-8 _zAvailable from publisher's website |
| 999 |
_c14277446 _d14277446 |
||